BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11387012)

  • 21. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent hepatocellular carcinoma and poorer overall survival in patients undergoing left-sided compared with right-sided partial hepatectomy.
    Valenzuela A; Ha NB; Gallo A; Bonham C; Ahmed A; Melcher M; Kim LH; Esquivel C; Concepcion W; Ayoub WS; Lutchman GA; Daugherty T; Nguyen MH
    J Clin Gastroenterol; 2015 Feb; 49(2):158-64. PubMed ID: 24804988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.
    Covey AM; Maluccio MA; Schubert J; BenPorat L; Brody LA; Sofocleous CT; Getrajdman GI; Fong Y; Brown KT
    Cancer; 2006 May; 106(10):2181-9. PubMed ID: 16596622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence.
    Huo TI; Lui WY; Wu JC; Huang YH; King KL; Loong CC; Lee PC; Chang FY; Lee SD
    World J Surg; 2004 Mar; 28(3):258-62. PubMed ID: 14961198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors for Deterioration of Remnant Liver Function After Hepatic Resection for Hepatocellular Carcinoma.
    Marukuchi R; Furukawa K; Iwase R; Yasuda J; Shiozaki H; Onda S; Gocho T; Shiba H; Yanaga K
    Anticancer Res; 2019 Oct; 39(10):5755-5760. PubMed ID: 31570478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
    Hu RH; Ho MC; Wu YM; Yu SC; Lee PH
    Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: a nationwide Taiwan database analysis of long-term outcome predictors.
    Shi HY; Wang SN; Wang SC; Chuang SC; Chen CM; Lee KT
    J Surg Oncol; 2014 Apr; 109(5):487-93. PubMed ID: 24293372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
    Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
    J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients.
    Lise M; Bacchetti S; Da Pian P; Nitti D; Pilati PL; Pigato P
    Cancer; 1998 Mar; 82(6):1028-36. PubMed ID: 9506346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
    Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization.
    Salem R; Gilbertsen M; Butt Z; Memon K; Vouche M; Hickey R; Baker T; Abecassis MM; Atassi R; Riaz A; Cella D; Burns JL; Ganger D; Benson AB; Mulcahy MF; Kulik L; Lewandowski R
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1358-1365.e1. PubMed ID: 23644386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.
    Ciria R; López-Cillero P; Gallardo AB; Cabrera J; Pleguezuelo M; Ayllón MD; Luque A; Zurera L; Espejo JJ; Rodríguez-Perálvarez M; Montero JL; de la Mata M; Briceño J
    Eur J Surg Oncol; 2015 Sep; 41(9):1153-61. PubMed ID: 26118317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma.
    Liu W; Wang K; Bao Q; Sun Y; Xing BC
    World J Surg Oncol; 2016 Mar; 14():62. PubMed ID: 26936459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study.
    Liu CL; Fan ST; Cheung ST; Lo CM; Ng IO; Wong J
    Ann Surg; 2006 Aug; 244(2):194-203. PubMed ID: 16858181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
    Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
    Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence of Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy.
    Zou H; Zhu CZ; Wang C; Wang ZS; Ma X; Han B; Wu LQ
    Am J Med Sci; 2017 Sep; 354(3):262-267. PubMed ID: 28918833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
    Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
    BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.